http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201591184-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
filingDate 2012-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201591184-A1
titleOfInvention APPLICATION OF PIDOTYMODE TO TREAT ATOPIC DERMATITIS
abstract The invention is directed to the use of pidotimod or a physiologically acceptable salt thereof for the treatment of atopic dermatitis. For the purpose of therapy, pidotimod or a physiologically acceptable salt thereof is used predominantly locally.
priorityDate 2012-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494519

Total number of triples: 18.